Similar Articles
481
Extremely high titer of hepatitis B surface antigen antibodies in a primary hepatocellular carcinoma patient: A case report
482
Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
483
Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
484
Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma
485
Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment
486
Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy
487
Characterization of metabolic landscape in hepatocellular carcinoma
488
Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
489
Deep learning applied to the imaging diagnosis of hepatocellular carcinoma
490
Application of artificial intelligence in preoperative imaging of hepatocellular carcinoma: Current status and future perspectives
Page 49 of 175 ( 1742 items )
<<
1
...
45
46
47
48
49
50
51
52
...
175
>>
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA